MOREPENLABPharmaceuticals
Morepen Laboratories Ltd — Balance Sheet
₹33.68
-2.22%
Morepen Laboratories Ltd Balance Sheet (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Common Stock | 109.58 Cr | 102.23 Cr | 102.23 Cr | 95.56 Cr | — |
| Total Liabilities Net Minority Interest | 591.14 Cr | 445.98 Cr | 358.05 Cr | 491.95 Cr | — |
| Total Non Current Liabilities Net Minority Interest | 90.49 Cr | 43.93 Cr | 36.88 Cr | 35.50 Cr | — |
| Non Current Deferred Taxes Liabilities | 6.98 Cr | 2.25 Cr | 2.69 Cr | 2.48 Cr | — |
| Long Term Debt And Capital Lease Obligation | 39.24 Cr | 3.36 Cr | 0.93 Cr | 1.32 Cr | — |
| Long Term Capital Lease Obligation | 13.48 Cr | — | — | — | — |
| Long Term Debt | 25.76 Cr | 3.36 Cr | 0.93 Cr | 1.32 Cr | — |
| Long Term Provisions | 39.85 Cr | 33.82 Cr | 29.74 Cr | 28.24 Cr | — |
| Current Liabilities | 500.65 Cr | 402.04 Cr | 321.16 Cr | 456.46 Cr | — |
| Other Current Liabilities | 21.61 Cr | 0.58 Cr | 0.58 Cr | 0.58 Cr | — |
| Current Debt And Capital Lease Obligation | 65.85 Cr | 25.64 Cr | 24.23 Cr | 17.25 Cr | — |
| Current Capital Lease Obligation | 12.22 Cr | — | — | — | — |
| Current Debt | 53.63 Cr | 25.64 Cr | 24.23 Cr | 17.25 Cr | — |
| Current Provisions | 19.60 Cr | 25.02 Cr | 16.24 Cr | 12.24 Cr | — |
| Payables | 363.30 Cr | 318.47 Cr | 250.67 Cr | 263.18 Cr | — |
| Accounts Payable | 363.30 Cr | 295.03 Cr | 226.88 Cr | 258.12 Cr | — |
| Total Assets | 1.78K Cr | 1.29K Cr | 1.11K Cr | 1.07K Cr | — |
| Total Non Current Assets | 618.73 Cr | 404.16 Cr | 354.33 Cr | 335.75 Cr | — |
| Other Non Current Assets | 86.79 Cr | 63.88 Cr | 63.92 Cr | 1000.00 | — |
| Non Current Prepaid Assets | 7.77 Cr | 7.16 Cr | 6.39 Cr | 5.87 Cr | — |
| Investmentin Financial Assets | 7.17 Cr | 1.30 Cr | 0.00 | 0.00 | — |
| Trading Securities | 7.17 Cr | 1.30 Cr | 0.00 | 0.00 | — |
| Goodwill And Other Intangible Assets | 146.52 Cr | 94.37 Cr | 100.23 Cr | 105.41 Cr | — |
| Other Intangible Assets | 72.04 Cr | 19.90 Cr | 25.76 Cr | 30.93 Cr | — |
| Goodwill | 74.47 Cr | 74.47 Cr | 74.47 Cr | 74.47 Cr | — |
| Net PPE | 370.33 Cr | 301.30 Cr | 247.65 Cr | 224.42 Cr | — |
| Gross PPE | 370.33 Cr | 562.70 Cr | 576.57 Cr | 541.04 Cr | — |
| Construction In Progress | 28.34 Cr | 88.09 Cr | 80.66 Cr | 77.77 Cr | — |
| Other Properties | 341.99 Cr | 213.20 Cr | 167.00 Cr | 146.65 Cr | — |
| Current Assets | 1.16K Cr | 889.04 Cr | 756.16 Cr | 734.30 Cr | — |
| Other Current Assets | 395.74 Cr | -3000.00 | 201.94 Cr | -1000.00 | — |
| Inventory | 299.96 Cr | 248.59 Cr | 228.89 Cr | 275.85 Cr | — |
| Other Receivables | 0.48 Cr | 6.58 Cr | 2.88 Cr | 3.50 Cr | — |
| Accounts Receivable | 324.76 Cr | 324.94 Cr | 263.25 Cr | 250.64 Cr | — |
| Cash Cash Equivalents And Short Term Investments | 138.42 Cr | 16.95 Cr | 21.67 Cr | 15.80 Cr | — |
| Other Short Term Investments | 111.04 Cr | 49.55 Cr | 40.15 Cr | 35.23 Cr | — |
| Cash And Cash Equivalents | 27.38 Cr | 16.95 Cr | 21.67 Cr | 15.80 Cr | — |
| Ordinary Shares Number | 54.80 Cr | 51.12 Cr | 51.12 Cr | 47.78 Cr | — |
| Share Issued | 54.80 Cr | 51.12 Cr | 51.12 Cr | 47.78 Cr | — |
| Net Debt | 52.01 Cr | 12.05 Cr | 3.50 Cr | 2.77 Cr | — |
| Total Debt | 105.10 Cr | 29.00 Cr | 25.16 Cr | 18.57 Cr | — |
| Tangible Book Value | 1.01K Cr | 752.86 Cr | 652.67 Cr | 473.15 Cr | — |
| Invested Capital | 1.24K Cr | 876.23 Cr | 778.07 Cr | 597.13 Cr | — |
| Working Capital | 658.72 Cr | 487.00 Cr | 435.00 Cr | 277.84 Cr | — |
| Net Tangible Assets | 1.01K Cr | 752.86 Cr | 652.67 Cr | 473.15 Cr | — |
| Capital Lease Obligations | 25.70 Cr | — | — | — | — |
| Common Stock Equity | 1.16K Cr | 847.23 Cr | 752.91 Cr | 578.56 Cr | — |
| Total Capitalization | 1.18K Cr | 850.59 Cr | 753.84 Cr | 579.88 Cr | — |
| Total Equity Gross Minority Interest | 1.19K Cr | 847.23 Cr | 752.45 Cr | 578.10 Cr | — |
| Minority Interest | 30.73 Cr | 0.00 | -0.46 Cr | -0.46 Cr | — |
| Stockholders Equity | 1.16K Cr | 847.23 Cr | 752.91 Cr | 578.56 Cr | — |
| Other Equity Interest | 1.05K Cr | 745.00 Cr | 650.68 Cr | 26.25 Cr | — |
| Capital Stock | 109.58 Cr | 102.23 Cr | 102.23 Cr | 95.56 Cr | — |
| Additional Paid In Capital | — | 446.02 Cr | 446.02 Cr | 308.04 Cr | 238.64 Cr |
| Other Payable | — | 19.70 Cr | 22.15 Cr | — | — |
| Total Tax Payable | — | 3.74 Cr | 1.65 Cr | 5.06 Cr | 2.86 Cr |
| Available For Sale Securities | — | 8.44 Cr | 6.38 Cr | — | 1.08 Cr |
| Accumulated Depreciation | — | -261.40 Cr | -328.92 Cr | -316.62 Cr | -370.98 Cr |
| Machinery Furniture Equipment | — | 373.57 Cr | 403.61 Cr | 380.43 Cr | 419.43 Cr |
| Buildings And Improvements | — | 99.61 Cr | 90.87 Cr | 81.41 Cr | 79.26 Cr |
| Land And Improvements | — | 1.43 Cr | 1.43 Cr | 1.43 Cr | 1.58 Cr |
| Properties | — | 0.00 | 0.00 | 0.00 | 0.00 |
| Restricted Cash | — | 35.17 Cr | 34.64 Cr | 30.17 Cr | 26.51 Cr |
| Prepaid Assets | — | 256.82 Cr | 204.85 Cr | 158.33 Cr | 92.48 Cr |
| Finished Goods | — | 62.55 Cr | 59.13 Cr | 79.52 Cr | 62.43 Cr |
| Work In Process | — | 37.41 Cr | 38.65 Cr | 35.82 Cr | 43.66 Cr |
| Raw Materials | — | 148.63 Cr | 131.11 Cr | 160.51 Cr | 69.24 Cr |
| Allowance For Doubtful Accounts Receivable | — | -2.94 Cr | -2.75 Cr | -5.83 Cr | -5.16 Cr |
| Gross Accounts Receivable | — | 327.87 Cr | 266.00 Cr | 256.47 Cr | 187.15 Cr |
| Cash Financial | — | 16.95 Cr | 21.67 Cr | 14.67 Cr | 41.39 Cr |
| Retained Earnings | — | 286.17 Cr | 190.01 Cr | 151.34 Cr | 54.65 Cr |
| Non Current Pension And Other Postretirement Benefit Plans | — | — | 29.74 Cr | 28.24 Cr | 25.39 Cr |
| Cash Equivalents | — | — | 0.00 | 1.13 Cr | 0.00 |
| Dividends Payable | — | — | — | 0.00 | 9.79 Cr |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Morepen Laboratories Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.